0001209191-19-003178.txt : 20190109 0001209191-19-003178.hdr.sgml : 20190109 20190109210924 ACCESSION NUMBER: 0001209191-19-003178 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190103 FILED AS OF DATE: 20190109 DATE AS OF CHANGE: 20190109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ong Tuyen CENTRAL INDEX KEY: 0001673178 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38217 FILM NUMBER: 19519152 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nightstar Therapeutics plc CENTRAL INDEX KEY: 0001711675 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O NIGHTSTAR, INC. STREET 2: 203 CRESCENT STREET, SUITE 303 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 781-778-7553 MAIL ADDRESS: STREET 1: C/O NIGHTSTAR, INC. STREET 2: 203 CRESCENT STREET, SUITE 303 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: Nightstar Therapeutics Ltd DATE OF NAME CHANGE: 20170712 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2019-01-03 2019-01-07 0 0001711675 Nightstar Therapeutics plc NITE 0001673178 Ong Tuyen C/O NIGHTSTAR, INC. 203 CRESCENT STREET, SUITE 303 WALTHAM MA 02453 0 1 0 0 Chief Development Officer Ordinary Shares 2019-01-03 4 S 0 4070 12.00 D 85471 D The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The original Form 4 has been amended to include all unvested restricted shares disclosed in the Reporting Person's Form 3 in Column 5 of this Form 4/A. This Form 4/A amends and restates, in its entirety, the original Form 4. /s/ Bryan Yoon, Attorney-in-Fact 2019-01-09